Origin of the U87MG glioma cell line: Good news and bad news

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

Lee, J., Kotliarova, S. E., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,345

Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens

Pollard, S. M., Yoshikawa, K., Clarke, I. D., Danovi, D., Stricker, S., Russell, R., Bayani, J., Head, R., Lee, M., Bernstein, M., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.014 · Cited by 1,025

LONG TERM CULTURE OF NORMAL AND NEOPLASTIC HUMAN GLIA

Pontén, J., & Macintyre, E. H. (1968) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1968.tb03502.x · Cited by 721

Absence of HeLa Cell Contamination in 169 Cell Lines Derived From Human Tumors2

Fogh, J., Wright, W. C., & Loveless, J. D. (1977) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/58.2.209 · Cited by 663

Check your cultures! A list of cross‐contaminated or misidentified cell lines

Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520 · cited 1×

The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes

Xie, Y., Bergström, T., Jiang, Y., Johansson, P., Marinescu, V. D., Lindberg, N., Segerman, A., Wicher, G., Niklasson, M., Baskaran, S., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.026 · Cited by 329

Cell line misidentification: the beginning of the end

American Type Culture Collection Standards Development Organization Workgroup ASN-0002 (2010) · Nature Reviews Cancer · doi:10.1038/nrc2852 · Cited by 266

DNA fingerprinting in forensics: past, present, future

Roewer, L. (2013) · Investigative Genetics · doi:10.1186/2041-2223-4-22 · Cited by 182

The Beginning of the End

Schraer, L., Borum, I., & Sathyan, T. G. (1995) · Cited by 113

A new model isolates glioblastoma clonal interactions and reveals unexpected modes for regulating motility, proliferation, and drug resistance

Davis, J. B., Krishna, S. S., Jomaa, R. A., Duong, C. T., Espina, V. A., Liotta, L. A., & Mueller, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-53850-7 · Cited by 16

Transcriptome analysis evinces anti-neoplastic mechanisms of hypericin: A study on U87 glioblastoma cell line

Ghiasvand, S., Javidi, M. A., Mohammadian, A., Mousavi, S. A., Shahriari, F., & Alavian, F. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118874 · Cited by 16

Novel modulators of p53-signaling encoded by unknown genes of emerging viruses

Alzhanova, D. V., Corcoran, K., Bailey, A., Long, K. M., Taft-Benz, S., Graham, R. L., Broussard, G. S., Heise, M. T., Neumann, G., Halfmann, P., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009033 · Cited by 17

M01 as a novel drug enhancer for specifically targeting the blood-brain barrier.

Breitkreuz-Korff, O., Tscheik, C., Vecchio, G. D., Dithmer, S., Walther, W., Orthmann, A., Wolburg, H., Haseloff, R. F., Schröder, L., Blasig, I. E., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.014 · Cited by 16

In situ hybridization to detect DNA amplification in extracellular vesicles

Casadei, L., Sarchet, P., de Faria, F. C. C., Calore, F., Nigita, G., Tahara, S., Cascione, L., Wabitsch, M., Hornicek, F. J., Grignol, V. P., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12251 · Cited by 16

Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies

Muzyka, L., Goff, N. K., Choudhary, N. R., & Koltz, M. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310456 · Cited by 15

Downregulation of COUP‑TFII inhibits glioblastoma growth via targeting MPC1

Xiao, B., Fan, Y., Ye, M., Lv, S., Xu, B., Chai, Y., Wu, M., & Zhu, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.8601 · Cited by 15

MNX1 reduces sensitivity to anoikis by activating TrkB in human glioma cells

Jiang, L., Chen, S., Zhao, D.-G., Yan, J., Chen, J., Yang, C., & Zheng, G. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9329 · Cited by 15

Dissecting the role of crosstalk between glioblastoma subpopulations in tumor cell spreading

Jubran, M. R., Rubinstein, A. M., Cojocari, I., Adejumobi, I. A., Mogilevsky, M., Tibi, S., Sionov, R. V., Verreault, M., Idbaïh, A., Karni, R., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-0199-y · Cited by 15

Liposomal Formulation of a PLA2-Sensitive Phospholipid–Allocolchicinoid Conjugate: Stability and Activity Studies In Vitro

Kobanenko, M. K., Tretiakova, D. S., Shchegravina, E. S., Антипова, Н. В., Boldyrev, I. A., Fedorov, A. Y., Vodovozova, E. L., & Onishchenko, N. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031034 · Cited by 15

Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells

Valdez, L., Cheng, B., Gonzalez, D., Rodriguez, R., Campano, P., Tsin, A. T. C., & Fang, X. (2022) · Oncotarget · doi:10.18632/oncotarget.28227 · Cited by 16

A SOX2-engineered epigenetic silencer factor represses the glioblastoma genetic program and restrains tumor development

Benedetti, V., Banfi, F., Zaghi, M., Moll‐Diaz, R., Massimino, L., Argelich, L., Bellini, E. N., Bido, S., Muggeo, S., Ordazzo, G., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn3986 · Cited by 15

αCT1 peptide sensitizes glioma cells to temozolomide in a glioblastoma organoid platform

Che, J., DePalma, T. J., Sivakumar, H., Mezache, L., Tallman, M. M., Venere, M., Swindle‐Reilly, K. E., Veeraraghavan, R., & Skardal, A. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28313 · Cited by 17

Oncogenic potential of PIK3CD in glioblastoma is exerted through cytoskeletal proteins PAK3 and PLEK2

Shao, W., Azam, Z., Guo, J., & To, S. S. T. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00821-8 · Cited by 14

Interaction of NF-κB and FOSL1 drives glioma stemness

Ramar, V., Guo, S., Hudson, B., Khedri, A., Guo, A. A., Li, J., & Liu, M. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05293-1 · Cited by 14

Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors

Oh, F., Modiano, J. F., Bachanová, V., & Vallera, D. A. (2020) · Biomolecules · doi:10.3390/biom10060956 · Cited by 14

CHIKV strains Brazil (wt) and Ross (lab-adapted) differ with regard to cell host range and antiviral sensitivity and show CPE in human glioblastoma cell lines U138 and U251

Hucke, F. I. L., Bestehorn, M., Bassetto, M., Brancale, A., Zanetta, P., & Bugert, J. J. (2022) · Virus Genes · doi:10.1007/s11262-022-01892-x · Cited by 14

The impact of temozolomide and lonafarnib on the stemness marker expression of glioblastoma cells in multicellular spheroids

Nakod, P. S., Kondapaneni, R. V., Edney, B., Kim, Y., & Rao, S. S. (2022) · Biotechnology Progress · doi:10.1002/btpr.3284 · Cited by 14

Correction: U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line

Clark, M. J., Homer, N., O’Connor, B. D., Chen, Z., Eskin, A., Lee, H., Merriman, B., & Nelson, S. F. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007392 · Cited by 14

Research advances of tissue-derived extracellular vesicles in cancers

Li, W., Zhu, J., Li, J., Jiang, Y., Sun, J., Xu, Y., Pan, H., Zhu, J., & Zhu, J. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05596-z · Cited by 13

Regulating glioma stem cells by hypoxia through the Notch1 and Oct3/4 signaling pathway

Zeng, F., Chen, H., Zhang, Z., Yao, T., Wang, G., Zeng, Q., Duan, S., & Zhan, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9442 · Cited by 13

Sulforaphane Causes Cell Cycle Arrest and Apoptosis in Human Glioblastoma U87MG and U373MG Cell Lines under Hypoxic Conditions

Sita, G., Graziosi, A., Hrelia, P., & Morroni, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011201 · Cited by 13

Gene therapy using genome‐edited iPS cells for targeting malignant glioma

Tamura, R., Miyoshi, H., Imaizumi, K., Yo, M., Kase, Y., Sato, T., Sato, M., Morimoto, Y., Sampetrean, O., Kohyama, J., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10406 · Cited by 13

Kunjin Virus, Zika Virus, and Yellow Fever Virus Infections Have Distinct Effects on the Coding Transcriptome and Proteome of Brain-Derived U87 Cells

Brand, C., Deschamps-Francoeur, G., Bullard, K. M., Scott, M. S., Geiss, B. J., & Bisaillon, M. (2023) · Viruses · doi:10.3390/v15071419 · Cited by 13

LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling

Xiao, Q., Dong, M., Cheng, F., Mao, F., Zong, W., Wu, K., Wang, H., Xie, R., Wang, B., Lei, T., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4482 · Cited by 13

Metabolic mapping of glioblastoma stem cells reveals NADH fluxes associated with glioblastoma phenotype and survival

Schroeder, A. B., Pointer, K. B., Clark, P. A., Datta, R., Kuo, J. S., & Eliceiri, K. W. (2020) · Journal of Biomedical Optics · doi:10.1117/1.jbo.25.3.036502 · Cited by 13

Inhibition of proliferation and migration and induction of apoptosis in glioma cells by silencing TLR4 expression levels via RNA interference

Liu, Y., Ju, Y., Liu, J., Chen, Y., Huo, X., & Liu, L. (2020) · Oncology Letters · doi:10.3892/ol.2020.12274 · Cited by 14

P2X7 receptor activity landscape in rat and human glioma cell lines

Matysniak, D. P., Nowak, N., Chumak, V., & Pomorski, P. (2020) · Acta Biochimica Polonica · doi:10.18388/abp.2020_2848 · Cited by 13

Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs

Lanskikh, D., Kuziakova, O., Baklanov, I., Penkova, A. O., Doroshenko, V., Buriak, I., Zhmenia, V., & Kumeiko, V. V. (2024) · Cells · doi:10.3390/cells13242085 · Cited by 12

miR‑204 functions as a tumor suppressor gene, at least partly by suppressing CYP27A1 in glioblastoma

Xin, J., Zheng, L., Sun, D., Li, X., Xu, P., & Tian, L. (2018) · Oncology Letters · doi:10.3892/ol.2018.8846 · Cited by 12

The protein kinase LKB1 promotes self‐renewal and blocks invasiveness in glioblastoma

Caja, L., Dadras, M. S., Mezheyeuski, A., Rodrigues‐Junior, D. M., Liu, S., Webb, A., Gomez‐Puerto, M. C., ten Dijke, P., Heldin, C., & Moustakas, A. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30542 · Cited by 12

Contribution of the Testosterone Androgen Receptor–PARD3B Signaling Axis to Tumorigenesis and Malignance of Glioblastoma Multiforme through Stimulating Cell Proliferation and Colony Formation

Yang, J.-D., Chen, J., Liu, S., & Chen, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164818 · Cited by 12

Failure to detect functional transfer of active K-Ras protein from extracellular vesicles into recipient cells in culture

Luhtala, N., & Hunter, T. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203290 · Cited by 12

MicroRNA-153 suppresses cell invasion by targeting SNAI1 and predicts patient prognosis in glioma

Zhao, W., Yin, C., Jiang, J., Kong, W., Xu, H., & Zhang, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.9706 · Cited by 12

Engineering a recombinant chlorotoxin as cell-targeted cytotoxic nanoparticles

Díaz, R. G., Sánchez‐García, L., Serna, N., Sánchez‐Chardi, A., Cano‐Garrido, O., Sánchez, J. M., Unzueta, U., Vázquez, E., & Villaverde, A. (2019) · Science China Materials · doi:10.1007/s40843-018-9391-y · Cited by 12

Bimodular Antiparallel G-Quadruplex Nanoconstruct with Antiproliferative Activity

Antipova, O. M., Samoylenkova, N. S., Savchenko, E., Zavyalova, E. G., Revishchin, A. V., Pavlova, G. V., & Kopylov, A. M. (2019) · Molecules · doi:10.3390/molecules24193625 · Cited by 12

In vitro demonstration of salinomycin as a novel chemotherapeutic agent for the treatment of SOX2‑positive glioblastoma cancer stem cells

Magrath, J. W., Raney, W. R., & Kim, Y. (2020) · Oncology Reports · doi:10.3892/or.2020.7642 · Cited by 12

Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell–cell viral transmission and cell–cell fusion

Narasimhulu, V. G. S., Bellamy-McIntyre, A. K., Laumaea, A., Lay, C.-S., Harrison, D. N., King, H. A. D., Drummer, H. E., & Poumbourios, P. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000537 · Cited by 11

Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme

Marcaccio, B., Crepaldi, M., Postuma, I., Simeone, E., Guidi, C., Fatemi, S., Ramos, R. L., Vercesi, V. I., Ferrari, C., Cansolino, L., et al. (2025) · Medical Physics · doi:10.1002/mp.17693 · Cited by 11

Deciphering pericyte-induced temozolomide resistance in glioblastoma with a 3D microphysiological system mimicking the biomechanical properties of brain tissue

Maity, S., Jewell, C., Yilgor, C., Kawakita, S., Sharma, S., Gomez, A., Mecwan, M. M., Falcone, N., Ermis, M., Monirizad, M., et al. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.05.038 · Cited by 11

Effect of Ras-guanine nucleotide release factor 1-mediated H-Ras/ERK signaling pathway on glioma

Pan, Y.-H., Chen, J., Sun, C., Ma, J.-F., & Li, X. (2021) · Brain Research · doi:10.1016/j.brainres.2020.147247 · Cited by 11

Homozygous EPRS1 missense variant causing hypomyelinating leukodystrophy-15 alters variant-distal mRNA m6A site accessibility

Khan, D., Ramachandiran, I., Vasu, K. I., China, A., Khan, K., Cumbo, F., Halawani, D., Terenzi, F., Zin, I., Long, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48549-x · Cited by 11

GSK3β‑mediated Ser156 phosphorylation modulates a BH3‑like domain in BCL2L12 during TMZ‑induced apoptosis and autophagy in glioma cells

Chu, C., Yang, M., Chou, C., Huang, W., Hsiao, B., Wang, Y., Chiou, S.-J., Loh, J., & Hong, Y. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3672 · Cited by 11

Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy

Fròsina, G., Ravetti, J. L., Corvò, R., Fella, M., Garrè, M. L., Levrero, F., Marcello, D., Marubbi, D., Morana, G., Mussap, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32578-w · Cited by 11

Targeting Ultrasmall Gold Nanoparticles with cRGD Peptide Increases the Uptake and Efficacy of Cytotoxic Payload

Perrins, R. D., McCarthy, L.-A., Robinson, A., Spry, K. L., Cognet, V., Ferreira, A., Porter, J. R., Garcı́a, C. E., Rodriguez, M. Á., Lopez, D., et al. (2022) · Nanomaterials · doi:10.3390/nano12224013 · Cited by 11

Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression

Kałuzińska‐Kołat, Ż., Kołat, D., Kośla, K., Płuciennik, E., & Bednarek, A. K. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1260409 · Cited by 10

The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields

Chen, D., Le, S. B., Manektalia, H., Liu, T., Hutchinson, T. E., O’Dell, A., Salhia, B., & Tran, D. D. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3643 · Cited by 12

Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia

Johanssen, T., McVeigh, L. E., Erridge, S., Higgins, G. S., Straehla, J. P., Frame, M. C., Aittokallio, T. A., Carragher, N. O., & Ebner, D. V. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1075559 · Cited by 10

Robust formation of optimal single spheroids towards cost‐effective in vitro three‐dimensional tumor models

Habra, K., Pearson, J. R. D., & McArdle, S. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13614 · Cited by 10

Effects of Ultraviolet Radiation on Glioma: Systematic Review

Pronin, S., Koh, C. H., & Hughes, M. A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26061 · Cited by 10

Human Olfactory Bulb Neural Stem Cells (Hu-OBNSCs) Can Be Loaded with Paclitaxel and Used to Inhibit Glioblastoma Cell Growth

Marei, H. E. S., Casalbore, P., Althani, A., Coccè, V., Cenciarelli, C., Alessandri, G., Brini, A. T., Parati, E. A., Bondiolotti, G., & Pessina, A. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11010045 · Cited by 10

All-Trans Retinoic Acid Fosters the Multifarious U87MG Cell Line as a Model of Glioblastoma

Pokorná, M., Hudec, M., Juříčková, I., Vácha, M., Polívková, Z., Kútna, V., Pala, J., Ovsepian, S. V., Černá, M., & O’Leary, V. B. (2021) · Brain Sciences · doi:10.3390/brainsci11060812 · Cited by 10

Deciphering the Action of Neuraminidase in Glioblastoma Models

Baeza, N., Bergès, R., Hein, V., Cabaret, S., Garcia, J., Gros, A., Tabouret, É., Tchoghandjian, A., Colin, C., & Figarella‐Branger, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411645 · Cited by 10

MiR‑500a‑5p promotes glioblastoma cell proliferation, migration and invasion by targeting chromodomain helicase DNA binding protein 5

Liu, Z., Su, D., Qi, X., & Ma, J. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9259 · Cited by 10

Building the case for the calcitonin receptor as a viable target for the treatment of glioblastoma

Gupta, P., Furness, S. G. B., Bittencourt, L. F. F., Hare, D. L., & Wookey, P. J. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920978110 · Cited by 10

Self-Assembling Amphiphilic ABA Triblock Copolymers of Hyperbranched Polyglycerol with Poly(tetrahydrofuran) and Their Nanomicelles as Highly Efficient Solubilization and Delivery Systems of Curcumin

Fecske, D., Kasza, G., Gyulai, G., Horváti, K., Szabó, M., Wacha, A., Varga, Z., Szarka, G., Thomann, Y., Thomann, R., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125866 · Cited by 9

MicroRNA-216b inhibits cell proliferation and invasion in glioma by directly targeting metadherin

Chen, Z., Wu, Y., Song, S., Zhu, X., & Zhu, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7829 · Cited by 9

A molecularly distinct subset of glioblastoma requires serum‐containing media to establish sustainable bona fide glioblastoma stem cell cultures

Maturi, N. P., Tan, E., Xie, Y., Sundström, A., Bergström, T., Jiang, Y., & Uhrbom, L. (2019) · Glia · doi:10.1002/glia.23773 · Cited by 9

Effects of miRNA-130a on the proliferation and apoptosis of glioma cell lines

Lu, K., Shen, H., Zhu, S. J., Bi, S., & Wu, S. (2018) · Oncology Letters · doi:10.3892/ol.2018.8878 · Cited by 9

Non‐enzymatic reaction of carnosine and glyceraldehyde‐3‐phosphate accompanies metabolic changes of the pentose phosphate pathway

Oppermann, H., Birkemeyer, C., Meixensberger, J., & Gaunitz, F. (2019) · Cell Proliferation · doi:10.1111/cpr.12702 · Cited by 9

Collagen and derivatives-based materials as substrates for the establishment of glioblastoma organoids

Sun, L., Jiang, Y., Tan, H. S., & Liang, R. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128018 · Cited by 8

Calotropis procera: A double edged sword against glioblastoma, inhibiting glioblastoma cell line growth by targeting histone deacetylases (HDAC) and angiogenesis

Alanazi, S., Farooq, M., Alazami, A. M., Baabbad, A., & Wadaan, M. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24406 · Cited by 8

Anti-Glioblastoma Potential and Phenolic Profile of Berry Juices

Kopjar, M., Raucher, D., Lila, M. A., & Šimunović, J. (2024) · Processes · doi:10.3390/pr12020242 · Cited by 8

Metabolomics identifies metabolite markers in plasma and extracellular vesicles within plasma in patients with asthma

Chang, C., Ma, Q.-W., Li, T.-L., Liu, J.-A., Hsieh, C.-H., & Chen, L. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.120010 · Cited by 8

The Effectiveness of Dichloroacetate on Human Glioblastoma Xenograft Growth Depends on Na+ and Mg2+ Cations

Stakišaitis, D., Damanskienė, E., Curkūnavičiūtė, R., Juknevičienė, M., Alonso, M. M., Valančiūtė, A., Ročka, S., & Balnytė, I. (2021) · Dose-Response · doi:10.1177/1559325821990166 · Cited by 8

Clinical significance of Iroquois Homeobox Gene - IRX1 in human glioma

Zhang, P., Liu, N., Xu, X., Wang, Z., Cheng, Y., Jin, W., Wang, X., Yang, H., Liu, H., Zhang, Y., et al. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8404 · Cited by 8

Human sodium iodide transporter gene-mediated imaging and therapy of mouse glioma, comparison between 188Re and 131I

Guo, R., Xi, Y., Zhang, M., Miao, Y., Zhang, M., & Li, B. (2018) · Oncology Letters · doi:10.3892/ol.2018.7752 · Cited by 8

Atypical cellular responses mediated by intracellular constitutive active TrkB (NTRK2) kinase domains and a solely intracellular NTRK2-fusion oncogene

Gupta, R., Dittmeier, M., Wohlleben, G., Nickl, V., Bischler, T., Luzak, V., Wegat, V., Doll, D., Sodmann, A., Bady, E., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00809-0 · Cited by 7

Pharmacotherapeutic Potential of Bitter Gourd (Momordica charantia) in Age-related Neurological Diseases

Adarmanabadi, S. M. H. H., Abadi, O. J. K., Amiri, A., tamannaeifar, R., Balanian, S., Rasekhjam, M., Samiazar, M. S., Hasanpour, S., Peiravi, S., Alijanzadeh, D., et al. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2304086 · Cited by 7

Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma

Behrmann, C. A., Ennis, K. N., Sarma, P., Wetzel, C., Clark, N. A., Handorf, K. M. V., Vallabhapurapu, S., Andreani, C., Reigle, J. K., Scaglioni, P. P., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0631 · Cited by 7

The Importance of Integrating Surgical Resection into Preclinical Glioblastoma Modeling

Volovetz, J., Buchwald, L. V., Straede, K., Kjær, A., Grabowski, M. M., Dhawan, A., Kristensen, B. W., & Lathia, J. D. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-0788 · Cited by 7

3-Bromofascaplysin is a prospective chemical compound for developing new chemotherapy agents in glioblastoma treatment

Lyakhova, I., Piatkova, M. A., Khotimchenko, Y. S., Zhidkov, M. E., Kantemirov, A. V., Khotimchenko, R., Bryukhovetskiy, A. S., Sharma, A., Sharma, H. S., & Bryukhovetskiy, I. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.011 · Cited by 7

Polymersomes for Sustained Delivery of a Chalcone Derivative Targeting Glioblastoma Cells

Alves, A. C., Silva, A. M., Moreira, J., Nunes, C., Reis, S., Pinto, M. M. M., Cidade, H. M., Rodrigues, F., Ferreira, D., Costa, P. C., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14010082 · Cited by 7

LC-ESI-MS/MS analysis of phenolic compounds and in vitro cytotoxicity and apoptosis-inducing effects of Nonea pulmonarioides extracts

Abdullah, F. O., Muhammed, H. H., Yılmaz, M. A., Çakır, O., & Tarhan, A. (2024) · Natural Product Research · doi:10.1080/14786419.2024.2306914 · Cited by 7

Preparation and evaluation of the PD0721‑DOX antibody‑drug conjugate targeting EGFRvIII to inhibit glioblastoma

Hu, M., Liu, H., Zhang, Y., Lu, D.-Y., Zheng, L., Wang, Y., Chen, S., & Liu, T. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12542 · Cited by 7

Pre-Clinical Models for CAR T-Cell Therapy for Glioma

Vandecandelaere, G., Ramapriyan, R., Gaffey, M., Richardson, L. G., Steuart, S. J., Tazhibi, M., Kalaw, A., Grewal, E. P., Sun, J., Curry, W. T., et al. (2024) · Cells · doi:10.3390/cells13171480 · Cited by 8

Recent advances in development and delivery of non-viral nucleic acid therapeutics for brain tumor therapy

Kögel, D., Temme, A., & Aigner, A. M. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108762 · Cited by 7

Bridging the gap between tumor and disease: Innovating cancer and glioma models

Cirigliano, S. M., & Fine, H. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20220808 · Cited by 8

Pre-Clinical Models and Potential Novel Therapies for Glioblastomas

Zalles, M., & Towner, R. A. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.gliomas.2021.chapter1 · Cited by 7

Type 1 Insulin-Like Growth Factor Receptor Nuclear Localization in High-Grade Glioma Cells Enhances Motility, Metabolism, and In Vivo Tumorigenesis

Martín, A., Fernández, M. C., Cattáneo, E. R., Schuster, C. D., Venara, M. C., Clément, F., Berenstein, A. J., Lombardi, M. G., Bergadá, I., Gutiérrez, M., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.849279 · Cited by 7

Overexpression of hsa-miR-939 follows by NGFR down-regulation and apoptosis reduction

Aghdaei, F. H., Soltani, B. M., Dokanehiifard, S., Mowla, S. J., & Soleimani, M. (2017) · Journal of Biosciences · doi:10.1007/s12038-017-9669-6 · Cited by 7

Induction and Assessment of Hypoxia in Glioblastoma Cells In Vitro

Gagner, J., Lechpammer, M., & Zagzag, D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7659-1_9 · Cited by 7

Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept Studies

Connor, K., Murray, D. W., Jarzabek, M. A., Tran, N. L., White, K., Dicker, P., Sweeney, K. J., O’Halloran, P. J., MacCarthy, B., Shiels, L. P., et al. (2020) · Cancers · doi:10.3390/cancers12123531 · Cited by 7

Treatment with Cyclic AMP Activators Reduces Glioblastoma Growth and Invasion as Assessed by Two-Photon Microscopy

Wartchow, K. M., Schmid, B., Tripal, P., Stadlbauer, A., Buchfelder, M., Gonçalves, C., & Kleindienst, A. (2021) · Cells · doi:10.3390/cells10030556 · Cited by 7

Polyunsaturated fatty acid-binding protein FABP7, an attractive metabolic target for inhibition of glioblastoma stem cells

Sun, Y., Mu, G., Xue, Z., Wang, S., Li, X., Ni, S., & Han, M. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noad238 · Cited by 7

mPEG-PLA micelles for nose-to-brain delivery of crizotinib-heptamethine cyanine dye conjugate for potential treatment of glioblastoma

Brar, H. K., Park, T., Dumo, C. J., Choi, P. J., Hwang, K., Nam, K. M., Kim, C., Dragunow, M., Wu, Z., Jose, J., et al. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01850-8 · Cited by 6

NANP targeting radiosensitizes glioblastoma through TNFR1 sialylation-driven mesenchymal shift

Ding, Y., Zhang, Z.-Y., Ezhilarasan, R., Modrek, A. S., Graciani, M., Karp, J. M., McManus, G., Jambhale, A. D., & Sulman, E. P. (2026) · Nature Communications · doi:10.1038/s41467-026-70853-x · Cited by 6

Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research

Sander, T., Ghanawi, J., Wilson, E., Muhammad, S., Macleod, M. R., & Kahlert, U. D. (2022) · BMJ Open Science · doi:10.1136/bmjos-2021-100272 · Cited by 6

Establishment and characteristics of GWH04, a new primary human glioblastoma cell line

Guo, D., Cheng, F., 毛峰, 万雪燕, Li, Y., Peng, P., Xu, S., Han, C., & Wang, B. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5429 · Cited by 6

A study on the production of extracellular vesicles derived from novel immortalized human placental mesenchymal stromal cells

Tong, Y., Sun, J. L., Jiang, X., Xu, J., Xiao, H., Wang, H., & Yang, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-87371-3 · Cited by 8

A quantitative characterization of the heterogeneous response of glioblastoma U-87 MG cell line to temozolomide

Dixit, P., Djafer-Cherif, I., Shah, S., Drabik, K., Traulsen, A., & Waclaw, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-99426-6 · Cited by 8

Photoactivatable Cyclometalated Ir(III) Compound Penetrates the Blood-Brain Barrier in 3D Spheroidal and Advanced 3D Organoid Models of Inherently Resistant and Aggressive Brain Tumors

Novohradský, V., Marco, A., Svitelova, M., Cutillas, N., Ruiz, J., & Brabec, V. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00145 · Cited by 6

Generation of induced neural stem cells with inducible IDH1R132H for analysis of glioma development and drug testing

Rosiak, K., Grot, D., & Rieske, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239325 · Cited by 6

Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cells

Baillache, D. J., Valero, T., Lorente‐Macías, Á., Bennett, D. J., Elliott, R. J. R., Carragher, N. O., & Unciti‐Broceta, A. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00454f · Cited by 6

Elucidating cellular response to treatment with viral immunotherapies in pediatric high-grade glioma and medulloblastoma

Thompson, E. M., Kang, K., Stevenson, K., Zhang, H., Gromeier, M., Ashley, D. M., Brown, M. C., & Friedman, G. K. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.101875 · Cited by 6

Monitoring drug metabolic pathways through extracellular vesicles in mouse plasma

Wu, X., Quan, M., Hadisurya, M., Hu, J., Liu, Y., Zhuang, Y., Li, L., Iliuk, A. B., Yang, J., Kuang, S., et al. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae023 · Cited by 6

Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss

Bouley, S. J., Grassetti, A. V., Allaway, R. J., Wood, M. D., Hou, H. W., Dasbach, I. R. B., Seibel, W. L., Wu, J. Y.-C., Gerber, S. A., Dragnev, K. H., et al. (2024) · Journal of Cell Science · doi:10.1242/jcs.262343 · Cited by 6

TNF-derived peptides inhibit tumour growth and metastasis through cytolytic effects on tumour lymphatics

Lu, W., Wang, Y., Zhang, Q., Owen, S. I., Green, M., Ni, T., Edwards, M., Li, Y., Zhang, L., Harris, A. L., et al. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13340 · Cited by 6

Recent Approaches Encompassing the Phenotypic Cell Heterogeneity for Anticancer Drug Efficacy Evaluation

Stulpinas, A., Imbrasaitė, A., Krestnikova, N., & Kalvelytė, A. V. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.89395 · Cited by 7

การแสดงออกของยนและคณลกษณะของเซลลตนกำเนดมะเรงในประชากรเซลลไลน U87MG glioblastoma

บุตรศรี, ร. (2020) · doi:10.58837/chula.the.2020.685

Increasing the accuracy of glioblastoma subtypes: Factoring in the tumor's cell of origin

Nelander, S. (2017) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1302907 · Cited by 1

Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin

Jiang, Y., Marinescu, V. D., Xie, Y., Jarvius, M., Maturi, N. P., Haglund, C., Olofsson, S. K., Lindberg, N., Olofsson, T., Leijonmarck, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.053 · Cited by 14

Establishment of attached and non‐attached cell lines from an uncommon human glioma

Westermark, B., Larsson, E., Brunk, U. T., Lubitz, W., & Mark, J. (1981) · International Journal of Cancer · doi:10.1002/ijc.2910280314 · Cited by 17

A study of the origin of human glioma based on cell lines and tumor specimens

Timin, G., Лахина, Ю. С., Gulyaev, D. A., & Tolkunova, E. N. (2016) · Cell and Tissue Biology · doi:10.1134/s1990519x16020103